The Nrf2 signaling pathway serves as a master regulator of cellular antioxidant defenses and a key therapeutic target for intestinal inflammatory disorders, including ulcerative colitis and Crohn's disease. This evidence concerns the gene NFE2L2 and ulcerative colitis.